Illumina Stock Buy Hold or Sell Recommendation

ILMN Stock  USD 138.30  0.38  0.27%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Illumina is 'Strong Hold'. Macroaxis provides Illumina buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Illumina positions. The advice algorithm takes into account all of Illumina's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Illumina's buy or sell advice are summarized below:
Real Value
162.16
Target Price
186.44
Hype Value
138.31
Market Value
138.3
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Illumina given historical horizon and risk tolerance towards Illumina. When Macroaxis issues a 'buy' or 'sell' recommendation for Illumina, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Illumina Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.
In addition, we conduct extensive research on individual companies such as Illumina and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Illumina. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Execute Illumina Buy or Sell Advice

The Illumina recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Illumina. Macroaxis does not own or have any residual interests in Illumina or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Illumina's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell IlluminaBuy Illumina
Strong Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Illumina has a Risk Adjusted Performance of 0.0095, Jensen Alpha of (0.26), Total Risk Alpha of (0.50), Sortino Ratio of (0.05) and Treynor Ratio of (0)
Macroaxis provides investment recommendation on Illumina to complement and cross-verify current analyst consensus on Illumina. Our trade recommendations engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Illumina is not overpriced, please check out all Illumina fundamentals, including its current ratio, total asset, and the relationship between the net income and price to earnings to growth . Given that Illumina has a price to earning of 49.12 X, we strongly advise you to confirm Illumina market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Illumina Trading Alerts and Improvement Suggestions

The company currently holds 2.26 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Illumina has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Illumina until it has trouble settling it off, either with new capital or with free cash flow. So, Illumina's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Illumina sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Illumina to invest in growth at high rates of return. When we think about Illumina's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 4.5 B. Net Loss for the year was (1.16 B) with profit before overhead, payroll, taxes, and interest of 3.15 B.
Over 95.0% of Illumina shares are owned by institutional investors
Latest headline from finance.yahoo.com: Bio-Manufacturing Market Expected to Reach USD 29.67 Billion by 2028

Illumina Returns Distribution Density

The distribution of Illumina's historical returns is an attempt to chart the uncertainty of Illumina's future price movements. The chart of the probability distribution of Illumina daily returns describes the distribution of returns around its average expected value. We use Illumina price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Illumina returns is essential to provide solid investment advice for Illumina.
Mean Return
0.01
Value At Risk
-3.83
Potential Upside
3.79
Standard Deviation
2.24
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Illumina historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Illumina Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Illumina is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Illumina backward and forwards among themselves. Illumina's institutional investor refers to the entity that pools money to purchase Illumina's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Alliancebernstein L.p.2023-12-31
2.7 M
Amvescap Plc.2023-12-31
2.6 M
Guardcap Asset Management Limited2023-12-31
M
Capital World Investors2023-12-31
M
Norges Bank2023-12-31
1.9 M
Goldman Sachs Group Inc2023-12-31
1.7 M
Nuveen Asset Management, Llc2023-12-31
1.7 M
Bank Of America Corp2023-12-31
1.5 M
Amundi2023-12-31
1.5 M
Vanguard Group Inc2023-12-31
18.2 M
Blackrock Inc2023-12-31
13.3 M
Note, although Illumina's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Illumina Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash898M(232M)(578M)779M(963M)(914.9M)
Free Cash Flow842M891M337M(74M)281M263.2M
Depreciation188M187M251M394M432M453.6M
Other Non Cash Items(138M)(147M)(994M)3.9B949M996.5M
Capital Expenditures209M189M208M466M196M131.7M
Net Income990M656M762M(4.4B)(1.2B)(1.1B)
End Period Cash Flow2.0B1.8B1.2B2.0B1.0B673.0M
Change To Inventory25M(12M)(58M)(135M)(20M)(21M)
Change To Netincome105M124M(288M)4.1B4.7B4.9B
Dividends Paid5M735M(511M)(937M)(843.3M)(801.1M)
Investments1.0B(143M)(1.1B)(591M)(231M)(242.6M)
Change Receivables(58M)89M(164M)(12M)(10.8M)(11.3M)
Net Borrowings731M(550M)471M991M1.1B1.2B

Illumina Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Illumina or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Illumina's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Illumina stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.26
β
Beta against NYSE Composite2.08
σ
Overall volatility
2.29
Ir
Information ratio -0.06

Illumina Volatility Alert

Illumina currently demonstrates below-average downside deviation. It has Information Ratio of -0.06 and Jensen Alpha of -0.26. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Illumina's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Illumina's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Illumina Implied Volatility

Illumina's implied volatility exposes the market's sentiment of Illumina stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Illumina's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Illumina stock will not fluctuate a lot when Illumina's options are near their expiration.

Illumina Fundamentals Vs Peers

Comparing Illumina's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Illumina's direct or indirect competition across all of the common fundamentals between Illumina and the related equities. This way, we can detect undervalued stocks with similar characteristics as Illumina or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Illumina's fundamental indicators could also be used in its relative valuation, which is a method of valuing Illumina by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Illumina to competition
FundamentalsIlluminaPeer Average
Return On Equity-0.19-0.31
Return On Asset-0.0053-0.14
Profit Margin(0.26) %(1.27) %
Operating Margin(0.03) %(5.51) %
Current Valuation23.24 B16.62 B
Shares Outstanding158.9 M571.82 M
Shares Owned By Insiders0.27 %10.09 %
Shares Owned By Institutions94.50 %39.21 %
Number Of Shares Shorted5.21 M4.71 M
Price To Earning49.12 X28.72 X
Price To Book3.84 X9.51 X
Price To Sales4.89 X11.42 X
Revenue4.5 B9.43 B
Gross Profit3.15 B27.38 B
EBITDA(1.07 B)3.9 B
Net Income(1.16 B)570.98 M
Cash And Equivalents2.01 B2.7 B
Cash Per Share6.62 X5.01 X
Total Debt2.26 B5.32 B
Debt To Equity0.38 %48.70 %
Current Ratio0.93 X2.16 X
Book Value Per Share36.13 X1.93 K
Cash Flow From Operations477 M971.22 M
Short Ratio2.80 X4.00 X
Earnings Per Share(7.34) X3.12 X
Price To Earnings To Growth4.30 X4.89 X
Target Price154.86
Number Of Employees10.59 K18.84 K
Beta1.19-0.15
Market Capitalization22.04 B19.03 B
Total Asset10.11 B29.47 B
Retained Earnings(19 M)9.33 B
Working Capital1.04 B1.48 B
Note: Exercise or conversion by Roy Whitfield of 800 shares of Illumina subject to Rule 16b-3 [view details]

Illumina Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Illumina . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Illumina Buy or Sell Advice

When is the right time to buy or sell Illumina? Buying financial instruments such as Illumina Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total2.5B3.5B2.3B2.4B
Total Assets15.2B12.3B10.1B10.6B

Use Investing Ideas to Build Portfolios

In addition to having Illumina in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Marijuana Thematic Idea Now

Marijuana
Marijuana Theme
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Check out Illumina Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Illumina Stock analysis

When running Illumina's price analysis, check to measure Illumina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Illumina is operating at the current time. Most of Illumina's value examination focuses on studying past and present price action to predict the probability of Illumina's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Illumina's price. Additionally, you may evaluate how the addition of Illumina to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Illumina's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
(7.34)
Revenue Per Share
28.506
Quarterly Revenue Growth
0.036
Return On Assets
(0.01)
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.